{"id":"W1547482497","doi":"10.1183/13993003/erj.42.suppl_57.p683","title":"PBI-compound, a novel first-in-class anti-fibrotic compound, reduces lung fibrosis in the bleomycin-induced lung fibrosis model: A comparative study with pirfenidone","year":2013,"lang":"en","type":"article","venue":"European Respiratory Journal","topic":"Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Aptose Biosciences (Canada)","funders":"","keywords":"Pirfenidone; CTGF; Bleomycin; Medicine; Idiopathic pulmonary fibrosis; Pulmonary fibrosis; Fibrosis; Lung; Combination therapy; Fibronectin; Inflammation; Pharmacology; Cancer research; Internal medicine; Extracellular matrix; Chemotherapy; Growth factor; Biochemistry; Chemistry; Receptor","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001152908,0.0004253482,0.0007416953,0.0004328185,0.0001686806,0.0001940669,0.0002598592,0.0002718577,0.001832941],"category_scores_gemma":[0.00008508849,0.0001175705,0.0004027098,0.0001742321,0.0002502412,0.0002437706,0.0001098716,0.0006475013,0.0003248751],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001402502,"about_ca_system_score_gemma":0.0002769357,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004363625,"about_ca_topic_score_gemma":0.001035633,"domain_scores_codex":[0.9999425,0.0000110241,0.000004758467,0.00001142614,0.00001347192,0.00001680641],"domain_scores_gemma":[0.9999281,0.000008822746,0.00001731196,0.000006018518,0.000008545886,0.00003116537],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.007409269,0.0026949,0.0009225469,0.0008544113,0.000148006,0.0003293898,0.00004824409,0.000506114,0.9475601,0.0002124127,0.0005906341,0.03872406],"study_design_scores_gemma":[0.003370899,0.07866779,0.02089234,0.00007986961,0.0005228093,0.002952582,0.00009144128,0.001847656,0.8722994,0.0001336544,0.01908434,0.00005719232],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9762344,0.01714941,0.002116806,0.0002947637,0.000141544,0.0002085389,0.0006293662,0.0001902377,0.003035093],"genre_scores_gemma":[0.9829186,0.01073208,0.002795759,0.0001147684,0.00007068524,0.0001260139,0.0007596191,0.00001924434,0.002463221],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001832941,"threshold_uncertainty_score":0.006131768,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03661332643813588,"score_gpt":0.2836514011642156,"score_spread":0.2470380747260797,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}